Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-241.44%
operating margin TTM
-265.69%
revenue TTM
10.14 Million
revenue per share TTM
0.05$
valuation ratios | |
|---|---|
| pe ratio | -11.42 |
| peg ratio | 0.63 |
| price to book ratio | -4.17 |
| price to sales ratio | 27.69 |
| enterprise value multiple | -11.66 |
| price fair value | -4.17 |
profitability ratios | |
|---|---|
| gross profit margin | 97.67% |
| operating profit margin | -265.69% |
| pretax profit margin | -244.34% |
| net profit margin | -241.44% |
| return on assets | -58.28% |
| return on equity | 44.28% |
| return on capital employed | -67.15% |
liquidity ratio | |
|---|---|
| current ratio | 17.44 |
| quick ratio | 17.44 |
| cash ratio | 16.48 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 7.77 |
| days of payables outstanding | 678.50 |
| cash conversion cycle | -670.74 |
| receivables turnover | 46.99 |
| payables turnover | 0.54 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.88 |
| debt equity ratio | -1.18 |
| long term debt to capitalization | 6.79 |
| total debt to capitalization | 6.59 |
| interest coverage | -5.94 |
| cash flow to debt ratio | -0.30 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.80 |
| cash per share | 3.60 |
| operating cash flow per share | -2.75 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.30 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -58.46 |
Frequently Asked Questions
When was the last time BridgeBio Pharma, Inc. (NASDAQ:BBIO) reported earnings?
BridgeBio Pharma, Inc. (BBIO) published its most recent earnings results on 30-09-2024.
What is BridgeBio Pharma, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BridgeBio Pharma, Inc. (NASDAQ:BBIO)'s trailing twelve months ROE is 44.28%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BridgeBio Pharma, Inc. (BBIO) currently has a ROA of -58.28%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BBIO's net profit margin stand at?
BBIO reported a profit margin of -241.44% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BBIO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 17.44 in the most recent quarter. The quick ratio stood at 17.44, with a Debt/Eq ratio of -1.18.